{"entity":{"type":"insider","cik":"0001675878","url":"/insider/0001675878","json_url":"/insider/0001675878.json","name":"Shames Richard S.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":6,"first":"2017-08-30","last":"2019-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Shames Richard S.","source":"filing","n_filings":6,"first_seen":"2017-08-30","last_seen":"2019-03-04"}],"transactions":[{"id":8118024,"accession":"0001209191-19-015927","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-015927","line_url":"/filing/0001209191-19-015927#line-2","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001675878","owner_name":"Shames Richard S.","owner_display_name":"Shames Richard S.","owner_url":"/insider/0001675878","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":657.0,"shares_display":"657","price_per_share":8.03,"price_display":"8.03","price_state":"stated","total_value":5275.71,"total_display":"5,275.71","total_whole":"5,276","shares_owned_after":32021.0,"shares_owned_after_display":"32,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-01","filed_date":"2019-03-04","scope":"insider"},{"id":8724043,"accession":"0001209191-19-008675","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-008675","line_url":"/filing/0001209191-19-008675","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001675878","owner_name":"Shames Richard S.","owner_display_name":"Shames Richard S.","owner_url":"/insider/0001675878","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2778.0,"shares_display":"2,778","price_per_share":7.741360691144709,"price_display":"7.74","price_state":"stated","total_value":21505.5,"total_display":"21,505.50","total_whole":"21,506","shares_owned_after":24178.0,"shares_owned_after_display":"24,178","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-06","filed_date":"2019-02-08","scope":"insider","n_lines":2},{"id":5039938,"accession":"0001209191-17-067392","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-067392","line_url":"/filing/0001209191-17-067392#line-2","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001675878","owner_name":"Shames Richard S.","owner_display_name":"Shames Richard S.","owner_url":"/insider/0001675878","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3529.0,"shares_display":"3,529","price_per_share":20.5,"price_display":"20.50","price_state":"stated","total_value":72344.5,"total_display":"72,344.50","total_whole":"72,345","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-22","filed_date":"2017-12-27","scope":"insider"},{"id":4423069,"accession":"0001209191-17-056551","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-056551","line_url":"/filing/0001209191-17-056551#line-2","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001675878","owner_name":"Shames Richard S.","owner_display_name":"Shames Richard S.","owner_url":"/insider/0001675878","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2017.0,"shares_display":"2,017","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":38323.0,"total_display":"38,323.00","total_whole":"38,323","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-05","filed_date":"2017-10-10","scope":"insider"},{"id":4907036,"accession":"0001209191-17-052501","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-052501","line_url":"/filing/0001209191-17-052501#line-1","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001675878","owner_name":"Shames Richard S.","owner_display_name":"Shames Richard S.","owner_url":"/insider/0001675878","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3687.0,"shares_display":"3,687","price_per_share":14.3078,"price_display":"14.31","price_state":"stated","total_value":52752.8586,"total_display":"52,752.86","total_whole":"52,753","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-12","filed_date":"2017-09-12","scope":"insider"},{"id":4629832,"accession":"0001209191-17-050815","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-050815","line_url":"/filing/0001209191-17-050815#line-2","is_derivative":false,"issuer_cik":"0001377121","issuer_name":"Protagonist Therapeutics, Inc","issuer_ticker":"PTGX","issuer_name_source":null,"issuer_url":"/issuer/0001377121","owner_cik":"0001675878","owner_name":"Shames Richard S.","owner_display_name":"Shames Richard S.","owner_url":"/insider/0001675878","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1512.0,"shares_display":"1,512","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":25704.0,"total_display":"25,704.00","total_whole":"25,704","shares_owned_after":1865.0,"shares_owned_after_display":"1,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-29","filed_date":"2017-08-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001377121","name":"Protagonist Therapeutics, Inc","url":"/issuer/0001377121","role":"Officer (Chief Medical Officer)","n_filings":6,"first_seen":"2017-08-30","last_seen":"2019-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001675878","retrieved_at":"2026-08-23T01:31:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}